<p>JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data</p>-Reference-Cited by-同舟云学术

JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data

Published:2020-09 Issue: Volume:Volume 13 Page:519-531
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Harrington Robert,Al Nokhatha Shamma Ahmad,Conway Richard^ORCID

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference91 articles.

1. Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an “anchor” drug?

2. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses

3. Direct targets of pSTAT5 signalling in erythropoiesis

4. Jak/Stat utilization table | cell signaling technology. Cellsignal.co.uk. Available from: https://www.cellsignal.co.uk/contents/resources-reference-tables/jak-stat-utilization-table/science-tables-jak-stat. Accessed July 14, 2020.

5. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitors versus tumor necrosis factor inhibitors in rheumatoid arthritis: meta-analytical comparison of efficacy and safety;Inflammopharmacology;2024-09-01

2. Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study;Advances in Rheumatology;2024-08-06

3. Up-and-Coming Drugs for the Treatment of Vitiligo;ANN DERMATOL;2024

4. Structural optimizations on the 7H-pyrrolo[2,3-d]pyrimidine scaffold to develop highly selective, safe and potent JAK3 inhibitors for the treatment of Rheumatoid arthritis;Bioorganic Chemistry;2024-08

5. Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?;Journal of Personalized Medicine;2024-07-22